See every side of every news story
Published loading...Updated

What's Going On With Alterity Therapeutics Shares Thursday? - Alterity Therapeutics (NASDAQ:ATHE)

Summary by Benzinga
Alterity Therapeutics Limited (NASDAQ:ATHE) shares are moving higher on Thursday after the company reported topline results from its Phase 2 clinical trial of ATH434 in early-stage multiple system atrophy (MSA). ATH434 demonstrated clinically meaningful results in slowing early-stage multiple system atrophy and showed a favorable safety profile. There is currently no FDA-approved, disease altering treatment for MSA. The trial enrolled 77 adults …

6 Articles

All
Left
Center
2
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Stockhead broke the news in on Thursday, January 30, 2025.
Sources are mostly out of (0)